AVTR

AVTR

USD

Avantor Inc. Common Stock

$13.585+0.155 (1.154%)

即時價格

Healthcare
Medical Instruments & Supplies
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$13.430

最高

$13.745

最低

$13.405

交易量

9.68M

公司基本面

市值

9.3B

行業

Medical Instruments & Supplies

國家

United States

交易統計

平均交易量

11.95M

交易所

NYQ

貨幣

USD

52週範圍

最低 $11.82當前 $13.585最高 $28

相關新聞

PR Newswire

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

查看更多
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
PR Newswire

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

查看更多
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference
Analyst Upgrades

Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14

Goldman Sachs analyst Matthew Sykes downgrades Avantor from Buy to Neutral and lowers the price target from $23 to $14.

查看更多
Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14
Analyst Upgrades

RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20

RBC Capital analyst Conor McNamara maintains Avantor with a Outperform and lowers the price target from $24 to $20.

查看更多
RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20
Analyst Upgrades

Stifel Downgrades Avantor to Hold, Lowers Price Target to $14

Stifel analyst Daniel Arias downgrades Avantor from Buy to Hold and lowers the price target from $26 to $14.

查看更多
Stifel Downgrades Avantor to Hold, Lowers Price Target to $14
Analyst Upgrades

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

Morgan Stanley analyst Tejas Savant downgrades Avantor from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Analyst Upgrades

Baird Maintains Outperform on Avantor, Lowers Price Target to $17

Baird analyst Catherine Schulte maintains Avantor with a Outperform and lowers the price target from $21 to $17.